Richard Proehl becomes vp of manufacturing at CML

Has spent more than 30 years in API manufacturing

Cambridge Major Laboratories (CML), a US producer of pharmaceutical intermediates and APIs, has welcomed Richard Proehl as vice president of manufacturing.

Proehl will be responsible for all plant scale manufacturing operations within the organisation, as well as all engineering and EHS functions. He brings more than 30 years of API manufacturing experience to the firm, based in Germantown, WI and has a strong focus on EHS and Quality Compliance.

‘Rick brings a wealth of experience to our team and his focus on quality and execution is a great fit with our company values,’ said Brian Scanlan, president and ceo of CML.

Prior to joining CML, Proehl was the St Louis site director for Covidien, where he was responsible for the company's largest API plant of about 900 employees.

‘The company's growth has been impressive and I will drive operational discipline in our manufacturing systems as we build on our strong fundamental capabilities and provide our customers with world class API manufacturing operations,’ said Proehl.

You may also like

Manufacturing

Cambridge Major Labs supports Summit antibiotic project

The chemistry outsourcing partner will help develop Summit’s antibiotic for Clostridium difficile
Manufacturing

API launch from new Cambridge Major Laboratories facility

This is the first commercial launch of an active pharmaceutical ingredient from its newest facility
Ingredients

AAIPharma Charleston sterile manufacturing receives MHRA approval

<p>International pharmaceutical services provider AAIPharma's sterile manufacturing plant in Charleston, South Carolina, US, has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to produce aseptic and lyophilised products.</p>
Ingredients

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients
Manufacturing

NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies
Ingredients

Pioneering AAV approach unlocks cause of rheumatoid arthritis pain

Karolinska Institute researchers use AAV products to uncover neural mechanisms behind rheumatoid arthritis pain
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed
Subscribe now